News

News

Vaxinano presents preclinical results of its anti-toxoplasma vaccine

Vaxinano presents preclinical results of its anti-toxoplasma vaccine

Thursday, December 05th 2019

Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.

...Read more

New Contract

New Contract

Monday, July 01st 2019

Vaxinano Announces the Signing of a Third Research and Development Program with a Leader in the Vaccine Industry.

...Read more

An <cite>E.coli</cite> vaccine as an alternative to the overuse of antibiotics in poultry

An E.coli vaccine as an alternative to the overuse of antibiotics in poultry

Thursday, June 06th 2019

Faced with the worldwide emergence of antibiotic resistance, Vaxinano obtains funding for research with Immunova Analises Biologicas and Lesaffre International to develop a vaccine against avian colibacillosis.

...Read more

Vaxinano in the selection of the 100 start-ups in which to invest in 2019

Vaxinano in the selection of the 100 start-ups in which to invest in 2019

27/03/2019

Visit the website

New contract

New contract

Wednesday, January 16th 2019

A new pharmaceutical industrial leader trusts Vaxinano for the development of veterinary vaccines.

...Read more

2018 Innovation competition : Vaxinano received by the secretaries of state

2018 Innovation competition : Vaxinano received by the secretaries of state

Tuesday, December 11st 2018

This December 11 was held the award ceremony of the 2018 Innovation competition where Vaxinano was rewarded in the field of Health.

...Read more

Vaxinano presents at the Maison de la Chimie

Vaxinano presents at the Maison de la Chimie

Wednesday, November 07th 2018

...Read more

New contract

New contract

Monday, September 10th 2018

Vaxinano has signed a research contract with a third industrial partner to develop a new veterinary vaccine.

...Read more

Contract renewal

Contract renewal

Saturday, September 01st 2018

The first industrial partner of Vaxinano, a world leader in the animal pharmaceutical industry, has renewed their contract and underlined their confidence in the company.

...Read more

New funding

New funding

Friday, May 04th 2018

Vaxinano has begun GMP-compliant pharmaceutical production in its vaccine platform

...Read more

Vaxinano : Safer vaccines

Vaxinano : Safer vaccines

01/04/2018

Visit the website Download the article

VAXINANO : nanoparticle-based vaccines against parasites, bacteria and viruses

VAXINANO : nanoparticle-based vaccines against parasites, bacteria and viruses

01/03/2018

Visit the website Download the article